Patents Assigned to Shanghai HEP Pharmaceutical Co., Ltd.
  • Compositions and methods for treating metabolic diseases
    Patent number: 11633454
    Abstract: The disclosure provides compositions and methods of treating a metabolic disease, such as, e.g., diabetes and hyperlipidemia, in a subject, by administering to the subject a therapeutically effective amount of a polypeptide derived from hepatitis B virus or a pharmaceutical composition comprising the polypeptide.
    Type: Grant
    Filed: May 31, 2017
    Date of Patent: April 25, 2023
    Assignee: SHANGHAI HEP PHARMACEUTICAL CO., LTD.
    Inventor: Hongli Liu
  • COMPOSITIONS AND METHODS FOR TREATING METABOLIC DISEASES
    Publication number: 20200323951
    Abstract: The disclosure provides compositions and methods of treating a metabolic disease, such as, e.g., diabetes and hyperlipidemia, in a subject, by administering to the subject a therapeutically effective amount of a polypeptide derived from hepatitis B virus or a pharmaceutical composition comprising the polypeptide.
    Type: Application
    Filed: May 31, 2017
    Publication date: October 15, 2020
    Applicant: SHANGHAI HEP PHARMACEUTICAL CO., LTD.
    Inventor: Hongli LIU
  • Formulations of hepalatide
    Patent number: 10603352
    Abstract: The present disclosure provides a drug formulation for hepalatide, comprising hepalatide and a buffer salt, and containing or not containing an osmotic regulator and/or an excipient.
    Type: Grant
    Filed: June 24, 2014
    Date of Patent: March 31, 2020
    Assignee: Shanghai HEP Pharmaceutical Co., Ltd.
    Inventor: Hongli Liu